Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideZBHZimmer Biomet
FinDog View：Neutral
| Metric | ABBV | ZBH |
|---|
| Close | 294.89 | 94.52 |
| Market Cap | $522B | $18.8B |
| 1M | +12.73% | +6.41% |
| P/E (TTM) | 81.4 | 22.3 |
| Forward P/E | 16.9 | 10.5 |
| P/E 5-Yr Percentile | 62 | 28 |
| P/S | 8.0 | 2.1 |
| P/B | — | 1.4 |
| Dividend Yield | 4.47% | 1.04% |
| Latest Quarter Revenue | $17.0B | $2.2B |
| Revenue YoY | +10.2% | +4.8% |
| Gross Margin | 74.7% | 70.8% |
| Latest Quarter EPS | 2.03 | 1.03 |
| Avg Post-Earnings Move | ±1.7% | ±2.1% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.58% | 5.00% |
| 90-Day Net Insider Buying | −$8.2M | −$0.82M |
ABBV · Revenue, Last 8 Quarters ($B)
ZBH · Revenue, Last 8 Quarters ($B)
